CoChat

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer

The DOI matches its Crossref record; 30 of the 35 references it cites were found in a registry or an index.

Abstract

Purpose To correlate FDG activity on PET with the expression of glucose transporter proteins Glut-1 and Glut-3 in patients with early stage non-small cell lung cancer (NSCLC).Methods Over a 5 year period, all patients with a PET scan and clinical stage I NSCLC underwent an immunohistochemical analysis of their tumor for Glut-1 and Glut-3 expression. The amount of FDG uptake in the primary lesion was measured by a standardized uptake ratio (SUR) and correlated with immunohistochemical results.Results Seventy-three patients with a mean age of 66 years had clinical stage I disease. The final pathologic stage showed 64 patients with stage IA/B disease, eight with stage IIA disease, and one patient with pathologic stage IIIA (T1N2) disease. Glut-1 transporter expression was significantly higher than Glut-3 (P<0.0001), and although there was some association between the SUR and Glut-1 (P=0.085) and SUR and Glut-3 (P=0.074) expression, this did not reach statistical significance.Conclusions Glut-1 and Glut-3 transporter expression did not demonstrate a statistically significant correlation with FDG uptake in potentially resectable lung cancer. It appears that these transporters alone do not affect the variation in FDG activity in early stage NSCLC.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0169-5002(00)00250-6

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Shelton, 1995, Diagnosis of bone metastasis in lung cancer by whole-body PET-PDG imaging: Comparison to conventional skeletal scintigraphy, J. Nucl. Med., 36, 200

Cited by

See all 73

Metadata

Authors
Marom, E. M., Aloia, T. A., Moore, M.-B., Hara, M., Herndon, J. E., Harpole, D. H., Goodman, P. C., & Patz, E. F.
Affiliations
  • Duke Medical Center (US)
  • Nagoya City University (JP)
Corresponding author
Marom, Edith M
Venue
Lung Cancer
Publisher
Elsevier BV
Published
2001-08
Volume
33
Issue
2-3
Pages
99-107
ISSN
0169-5002 (ISSN-L)
OpenAlex
W2153804216
Cited by
69
References
35
Citations by year
2023: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
1.26
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Lung Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
non-small cell lung cancer, early-stage lung cancer, FDG-PET, glucose transporter 1, GLUT3, FDG uptake, tumor glucose metabolism, immunohistochemistry, stage I non-small cell lung cancer
MeSH terms
Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Humans, Immunoenzyme Techniques, Lung, Lung Neoplasms, Male, Middle Aged, Monosaccharide Transport Proteins, Nerve Tissue Proteins, Tomography, Emission-Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18, Glucose Transporter Type 1, Glucose Transporter Type 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. https://app.cochat.ai/papers/10.1016/s0169-5002(00)00250-6
The paper
Marom, E. M., Aloia, T. A., Moore, M.-B., Hara, M., Herndon, J. E., Harpole, D. H., Goodman, P. C., & Patz, E. F. (2001). Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer. https://doi.org/10.1016/s0169-5002(00)00250-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.